Strategy Asset Managers LLC Has $4.64 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Strategy Asset Managers LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,171 shares of the healthcare conglomerate’s stock after selling 584 shares during the quarter. Strategy Asset Managers LLC’s holdings in UnitedHealth Group were worth $4,639,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth $32,000. Pillar Financial Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $40,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group during the third quarter valued at approximately $57,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Down 0.0 %

UNH stock opened at $515.47 on Friday. The company has a market capitalization of $471.51 billion, a PE ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company’s 50 day moving average price is $508.81 and its two-hundred day moving average price is $544.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the company posted $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Analysts Set New Price Targets

UNH has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.